13 Nov 2024

Reference: CIR-2024-00000218

To all Health facilities and healthcare practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the circulars issued by the MOHAP for perusal and adherence to what is stated.

Circular No. 10016 for the year 2024 Safety Update of Pharmaceutical Product.

Thanks in advance for your good co-operation

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

Signifor ( Pasireotide ) اضافة تحذير على المنتج الطبي ---.pdf

download